This review summarizes the current state-of-the-art of radiolabeled nanoparticles for
molecular imaging and internal radiotherapy applications targeting cancer. With the capacity …

In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer
diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora …

Cancer is the second leading cause of death in the world. Radiolabeled nanocarriers or
nanoparticles can be designed and used for cancer diagnostic and therapeutic purposes …

Current progress in nanomedicine has exploited the possibility of designing tumor‐targeted
nanocarriers being able to deliver radionuclide payloads in a site or molecular selective …

Radiotherapy has been, and will continue to be, a critical modality to treat cancer. Since the
discovery of radiation-induced cytotoxicity in the late 19th century, both external and internal …

In this study, we cover the convergence of radiochemistry for imaging and therapy with
advances in nanoparticle (NP) design for biomedical applications. We first explore NP …

Introduction: The integration of diagnostic testing for the presence of a molecular target is of
interest to predict successful targeted radionuclide therapy (TRNT). This so-called …

Nanoparticles can be near infrared (NIR)-fluorescent (eg, gold nanoparticles, quantum dots
or carbon nanotubes) or can have magnetic properties (eg, iron oxide nanoparticles). These …

Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …

Nano-engineered particles have been developed to reach specific molecular targets on
diseased cells and have been used in various experimental and clinical conditions. The …